15.56
price up icon0.97%   0.15
after-market アフターアワーズ: 15.56
loading
前日終値:
$15.41
開ける:
$15.42
24時間の取引高:
815.23K
Relative Volume:
1.44
時価総額:
$631.98M
収益:
-
当期純損益:
$-168.05M
株価収益率:
-3.0331
EPS:
-5.13
ネットキャッシュフロー:
$-146.15M
1週間 パフォーマンス:
+7.38%
1か月 パフォーマンス:
-2.14%
6か月 パフォーマンス:
+12.02%
1年 パフォーマンス:
-73.77%
1日の値動き範囲:
Value
$15.03
$15.76
1週間の範囲:
Value
$13.60
$15.76
52週間の値動き範囲:
Value
$9.12
$72.37

Keros Therapeutics Inc Stock (KROS) Company Profile

Name
名前
Keros Therapeutics Inc
Name
セクター
Healthcare (1138)
Name
電話
617-314-6297
Name
住所
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA
Name
職員
148
Name
Twitter
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
KROS's Discussions on Twitter

KROS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
KROS
Keros Therapeutics Inc
15.56 469.48M 0 -168.05M -146.15M -5.13
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.44 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.90 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
584.74 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
814.17 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.54 34.68B 4.56B -176.77M 225.30M -1.7177

Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-20 開始されました Wells Fargo Overweight
2025-06-10 ダウングレード BofA Securities Buy → Neutral
2025-01-21 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-01-17 ダウングレード Wedbush Outperform → Neutral
2024-12-16 ダウングレード Guggenheim Buy → Neutral
2024-12-16 繰り返されました Oppenheimer Outperform
2024-12-13 繰り返されました H.C. Wainwright Buy
2024-12-12 ダウングレード BTIG Research Buy → Neutral
2024-12-12 ダウングレード TD Cowen Buy → Hold
2024-12-12 ダウングレード William Blair Outperform → Mkt Perform
2024-11-05 開始されました Jefferies Buy
2024-10-24 開始されました Cantor Fitzgerald Overweight
2024-10-16 開始されました Scotiabank Sector Outperform
2024-09-23 開始されました Guggenheim Buy
2024-06-25 開始されました Oppenheimer Outperform
2024-02-21 開始されました William Blair Outperform
2023-12-08 開始されました Wells Fargo Overweight
2023-07-31 開始されました Wedbush Outperform
2023-07-26 開始されました BofA Securities Buy
2023-02-14 開始されました Cowen Outperform
2022-10-18 開始されました Truist Buy
2022-07-26 開始されました BTIG Research Buy
2020-12-08 繰り返されました H.C. Wainwright Buy
2020-05-04 開始されました H.C. Wainwright Buy
2020-05-04 開始されました Jefferies Buy
2020-05-04 開始されました Piper Sandler Overweight
2020-05-04 開始されました SVB Leerink Outperform
すべてを表示

Keros Therapeutics Inc (KROS) 最新ニュース

pulisher
Oct 21, 2025

Technical Reactions to KROS Trends in Macro Strategies - news.stocktradersdaily.com

Oct 21, 2025
pulisher
Oct 21, 2025

Keros Therapeutics (KROS) Moves 9.8% Higher: Will This Strength Last? - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Can Keros Therapeutics Inc. recover in the next quarterMarket Risk Summary & Community Consensus Picks - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Using flow based indicators on Keros Therapeutics Inc.July 2025 Update & AI Powered Market Entry Strategies - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Keros Therapeutics Inc. stock trendline breakdownWeekly Investment Recap & AI Optimized Trading Strategy Guides - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Keros Therapeutics (NASDAQ:KROS) Trading Up 10.8%Still a Buy? - MarketBeat

Oct 20, 2025
pulisher
Oct 20, 2025

Why Keros Therapeutics Inc. stock remains undervaluedLong Setup & Accurate Entry/Exit Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 18:43:57 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Reversal indicators forming on Keros Therapeutics Inc. stockPortfolio Risk Report & Weekly High Potential Stock Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What hedge fund activity signals for Keros Therapeutics Inc. stockTrade Ideas & Long-Term Investment Growth Plans - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Can trapped investors hope for a rebound in Keros Therapeutics Inc.July 2025 Catalysts & Reliable Momentum Entry Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Keros Therapeutics Inc. stock daily chart insightsMarket Performance Recap & Capital Efficient Trade Techniques - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Keros Therapeutics (KROS) Launches $194.4 Million Stock Buyback - GuruFocus

Oct 20, 2025
pulisher
Oct 20, 2025

Wells Fargo & Company Initiates Coverage on Keros Therapeutics (NASDAQ:KROS) - MarketBeat

Oct 20, 2025
pulisher
Oct 20, 2025

Will breakout in Keros Therapeutics Inc. lead to full recovery2025 Fundamental Recap & Reliable Price Breakout Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Keros Therapeutics (KROS) Initiates Tender Offer for Share Buyback - GuruFocus

Oct 20, 2025
pulisher
Oct 20, 2025

Keros Therapeutics Launches Tender Offer for Up to $194.4 Million of Shares - MarketScreener

Oct 20, 2025
pulisher
Oct 20, 2025

Keros Therapeutics (KROS) Initiates $194.4M Stock Buyback Progra - GuruFocus

Oct 20, 2025
pulisher
Oct 20, 2025

Keros Therapeutics launches $194.4 million share repurchase tender offer - Investing.com

Oct 20, 2025
pulisher
Oct 20, 2025

Keros (KROS) launches fixed-price cash tender offer for shares - Stock Titan

Oct 20, 2025
pulisher
Oct 20, 2025

$194.4M Tender Offer — Keros Therapeutics to Repurchase at $17.75; Part of $375M Program. Expires Nov. 18, 2025 - Stock Titan

Oct 20, 2025
pulisher
Oct 19, 2025

Historical volatility pattern of Keros Therapeutics Inc. visualized2025 Valuation Update & High Accuracy Trade Alerts - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Keros Therapeutics (NASDAQ:KROS) Major Shareholder Sells $84,975,125.25 in Stock - MarketBeat

Oct 18, 2025
pulisher
Oct 18, 2025

Chipmakers Recap: Is Keros Therapeutics Inc. stock supported by strong fundamentalsWeekly Profit Report & Real-Time Volume Analysis - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

What momentum indicators show for Keros Therapeutics Inc. stockQuarterly Profit Summary & Daily Entry Point Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Keros Therapeutics Inc. stock supported by strong fundamentalsWeekly Trade Review & Accurate Buy Signal Notifications - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Keros Therapeutics Inc. stock a buy on dipsWatch List & Advanced Swing Trade Entry Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Earnings visualization tools for Keros Therapeutics Inc.Trade Ideas & Daily Stock Momentum Reports - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Pontifax funds sell Keros Therapeutics (KROS) shares for $84.97m By Investing.com - Investing.com Australia

Oct 17, 2025
pulisher
Oct 17, 2025

Sarcopenia Market Insights Highlight Expanding Outlook Till - openPR.com

Oct 17, 2025
pulisher
Oct 17, 2025

Sarcopenia Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | TNF Pharma, Lipocine, Biophytis, ImmunoForge, Rejuvenate Biomed, Keros Therapeutics, BPGbio, Oncocross - Barchart.com

Oct 17, 2025
pulisher
Oct 17, 2025

Pontifax funds sell Keros Therapeutics (KROS) shares for $84.97m - Investing.com India

Oct 17, 2025
pulisher
Oct 17, 2025

KROS insiders file Form 4; Pontifax funds report stock sales - Stock Titan

Oct 17, 2025
pulisher
Oct 17, 2025

How to recover losses in Keros Therapeutics Inc. stock2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Is Keros Therapeutics Inc. stock poised for growthSwing Trade & Community Consensus Picks - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Keros Therapeutics, Inc. (KROS) Stock Analysis: Unpacking a 67% Potential Upside Amidst Robust Revenue Growth - DirectorsTalk Interviews

Oct 17, 2025
pulisher
Oct 17, 2025

Forecasting Keros Therapeutics Inc. price range with options dataWall Street Watch & Long-Term Capital Growth Ideas - newser.com

Oct 17, 2025
pulisher
Oct 16, 2025

Keros Therapeutics (NASDAQ:KROS) Major Shareholder Adar1 Capital Management, Llc Sells 5,389,264 Shares - MarketBeat

Oct 16, 2025
pulisher
Oct 16, 2025

Keros Therapeutics, Inc. (NASDAQ:KROS) Looks Inexpensive But Perhaps Not Attractive Enough - 富途牛牛

Oct 16, 2025
pulisher
Oct 16, 2025

Keros Therapeutics Unveils Major Capital Return Initiative Amid Leadership Reshuffle - AD HOC NEWS

Oct 16, 2025
pulisher
Oct 15, 2025

Keros Therapeutics Sparks Market Interest With Nasdaq Futures - Kalkine Media

Oct 15, 2025
pulisher
Oct 15, 2025

Keros Therapeutics Plans Major Buyback And Tender Offer - Finimize

Oct 15, 2025
pulisher
Oct 15, 2025

Adar1 partners sells Keros Therapeutics (KROS) shares worth $95.6m By Investing.com - Investing.com Nigeria

Oct 15, 2025
pulisher
Oct 15, 2025

Adar1 partners sells Keros Therapeutics (KROS) shares worth $95.6m - Investing.com

Oct 15, 2025
pulisher
Oct 15, 2025

Keros Therapeutics (NASDAQ:KROS) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat

Oct 15, 2025

Keros Therapeutics Inc (KROS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$36.84
price down icon 1.71%
$88.06
price up icon 0.87%
$29.92
price down icon 0.70%
$106.23
price down icon 0.62%
$160.40
price down icon 2.97%
biotechnology ONC
$313.54
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):